• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺切除术对 5 期慢性肾脏病患者血浆甲状旁腺激素片段和心率变异性的影响。

Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients.

机构信息

Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

Department of Nephrology, Taizhou People's Hospital, Taizhou, China.

出版信息

Ren Fail. 2021 Dec;43(1):890-899. doi: 10.1080/0886022X.2021.1931318.

DOI:10.1080/0886022X.2021.1931318
PMID:34044733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8168729/
Abstract

INTRODUCTION

Circulating intact parathyroid hormone (iPTH) levels include full-length (1-84) PTH and long C-PTH fragments, but primarily (7-84) PTH, which have been reported to have antagonistic effects on the bones and kidneys. However, their effects on the cardiovascular system remain unclear. In this study, the relationships between the plasma PTH fragments levels and heart rate variability (HRV) in stage 5 chronic kidney disease (CKD5) patients are explored. Furthermore, the effects of parathyroidectomy (PTX) on the above indices are investigated.

METHODS

In this cross-sectional study, 164 healthy controls and 354 CKD5 patients, including 208 secondary hyperparathyroidism (SHPT) subgroup with PTX, were enrolled. Circulating (7-84) PTH levels were calculated by subtracting plasma (1-84) PTH levels from iPTH levels. The HRV parameters were measured using a 24-hour Holter.

RESULTS

The baseline levels of plasma iPTH, (1-84) PTH, and (7-84) PTH in the CKD5 patients were 930.40 (160.65, 1792.50) pg/mL, 448.60 (99.62, 850.45) pg/mL, and 468.20 (54.22, 922.55) pg/mL, respectively. In the CKD5 patients, plasma (1-84) PTH levels were independently correlated with the standard deviation of the normal-to-normal R-R intervals (SDNN) and the standard deviation of the five-minute average of the normal R-R intervals (SDANN). With a median follow up time of 6.50 months after PTX in the SHPT patients ( = 30), improved SDNN and SDANN markers were related with decreased (1-84) PTH levels. Furthermore, an improved SDNN was related with decreased (7-84) PTH levels.

CONCLUSIONS

The CKD5 patients' baseline (1-84) PTH levels were correlated with the SDNN and SDANN. After PTX, an improved SDNN was related with decreased (1-84) PTH and (7-84) PTH levels, while improved SDANN was related with decreased (1-84) PTH levels. No antagonistic effects of (1-84) PTH and (7-84) PTH on HRV were found in the CKD5 patients.

摘要

简介

循环完整甲状旁腺激素 (iPTH) 水平包括全长 (1-84) PTH 和长 C-PTH 片段,但主要是 (7-84) PTH,据报道其对骨骼和肾脏有拮抗作用。然而,它们对心血管系统的影响尚不清楚。本研究探讨了 5 期慢性肾脏病 (CKD5) 患者血浆 PTH 片段水平与心率变异性 (HRV) 之间的关系。此外,还研究了甲状旁腺切除术 (PTX) 对上述指标的影响。

方法

本横断面研究纳入了 164 名健康对照者和 354 名 CKD5 患者,其中 208 名为继发性甲状旁腺功能亢进症 (SHPT) 亚组接受了 PTX。通过从 iPTH 水平中减去血浆 (1-84) PTH 水平来计算循环 (7-84) PTH 水平。使用 24 小时动态心电图仪测量 HRV 参数。

结果

CKD5 患者的基础 iPTH、(1-84) PTH 和 (7-84) PTH 水平分别为 930.40(160.65,1792.50)pg/ml、448.60(99.62,850.45)pg/ml 和 468.20(54.22,922.55)pg/ml。在 CKD5 患者中,血浆 (1-84) PTH 水平与正常 R-R 间期标准差 (SDNN) 和正常 R-R 间期五分位平均标准差 (SDANN) 独立相关。在 SHPT 患者接受 PTX 后中位随访时间为 6.50 个月(n=30)时,SDNN 和 SDANN 标志物的改善与 (1-84) PTH 水平的降低有关。此外,SDNN 的改善与 (7-84) PTH 水平的降低有关。

结论

CKD5 患者的基础 (1-84) PTH 水平与 SDNN 和 SDANN 相关。PTX 后,SDNN 的改善与 (1-84) PTH 和 (7-84) PTH 水平的降低有关,而 SDANN 的改善与 (1-84) PTH 水平的降低有关。在 CKD5 患者中,未发现 (1-84) PTH 和 (7-84) PTH 对 HRV 有拮抗作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/40d29b0d4a5b/IRNF_A_1931318_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/384c28e35cfb/IRNF_A_1931318_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/ebd9e6c46a4b/IRNF_A_1931318_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/40d29b0d4a5b/IRNF_A_1931318_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/384c28e35cfb/IRNF_A_1931318_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/ebd9e6c46a4b/IRNF_A_1931318_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f6/8168729/40d29b0d4a5b/IRNF_A_1931318_F0003_C.jpg

相似文献

1
Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients.甲状旁腺切除术对 5 期慢性肾脏病患者血浆甲状旁腺激素片段和心率变异性的影响。
Ren Fail. 2021 Dec;43(1):890-899. doi: 10.1080/0886022X.2021.1931318.
2
Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease.甲状旁腺切除术对5期慢性肾脏病患者血浆免疫反应性甲状旁腺激素(iPTH)和(1-84)甲状旁腺激素水平的影响
Horm Metab Res. 2018 Oct;50(10):761-767. doi: 10.1055/a-0723-2807. Epub 2018 Sep 17.
3
Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.甲状旁腺切除术对5期慢性肾病患者血骨标志物及心率变异性的影响。
Int Urol Nephrol. 2018 Dec;50(12):2279-2288. doi: 10.1007/s11255-018-1995-6. Epub 2018 Oct 25.
4
Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD.5期慢性肾脏病患者的血浆成纤维细胞生长因子23水平与心率变异性
Osteoporos Int. 2015 Jan;26(1):395-405. doi: 10.1007/s00198-014-2862-7. Epub 2014 Sep 16.
5
Parathyroidectomy Is Associated With Reversed Nondipping Heart Rate That Impacts Mortality in Chronic Kidney Disease Patients.甲状旁腺切除术与慢性肾病患者中影响死亡率的反向非勺型心率相关。
Endocr Pract. 2022 Feb;28(2):148-158. doi: 10.1016/j.eprac.2021.02.007. Epub 2021 Feb 19.
6
Diagnostic Values of Intraoperative (1-84) Parathyroid Hormone Levels are Superior to Intact Parathyroid Hormone for Successful Parathyroidectomy in Patients With Chronic Kidney Disease.术中(1-84)甲状旁腺激素水平的诊断价值优于完整甲状旁腺激素,可用于慢性肾脏病患者甲状旁腺切除术的成功预测。
Endocr Pract. 2021 Nov;27(11):1065-1071. doi: 10.1016/j.eprac.2021.04.006. Epub 2021 Apr 22.
7
Value of Intraoperative Parathyroid Hormone Assay during Parathyroidectomy in Dialysis and Renal Transplant Patients with Secondary and Tertiary Hyperparathyroidism.透析及肾移植患者继发性和三发性甲状旁腺功能亢进症行甲状旁腺切除术时术中甲状旁腺激素测定的价值
Nephron. 2018;138(2):119-128. doi: 10.1159/000482016. Epub 2017 Nov 9.
8
Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.继发性甲状旁腺功能亢进患者甲状旁腺切除术中血浆完整甲状旁腺激素和全甲状旁腺激素水平的序贯变化
World J Surg. 2005 Feb;29(2):169-73. doi: 10.1007/s00268-004-7489-y.
9
Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients.甲状旁腺切除术后甲状旁腺激素水平降低可降低慢性血液透析患者的心血管死亡率。
Clin Exp Nephrol. 2016 Oct;20(5):808-814. doi: 10.1007/s10157-015-1208-x. Epub 2015 Dec 17.
10
Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.慢性肾脏病患者甲状旁腺切除术:不同技术对继发性甲状旁腺功能亢进症生化和临床转归的影响。
Surgery. 2018 Feb;163(2):381-387. doi: 10.1016/j.surg.2017.09.005. Epub 2017 Nov 13.

引用本文的文献

1
The Clinical Efficacy Evaluation of the KHA-200 Hemoperfusion Device in the Treatment of End-Stage Renal Disease Patients Undergoing Blood Purification Therapy.KHA-200血液灌流装置治疗接受血液净化治疗的终末期肾病患者的临床疗效评估
Kidney Dis (Basel). 2025 Mar 29;11(1):270-282. doi: 10.1159/000545262. eCollection 2025 Jan-Dec.
2
Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease.慢性肾脏病患者的血液-骨骼代谢生物标志物与贫血之间的关系。
Ren Fail. 2023 Dec;45(1):2210227. doi: 10.1080/0886022X.2023.2210227.
3
Full-length versus intact PTH concentrations in pseudohypoparathyroidism type 1 and primary hyperparathyroidism: clinical evaluation of immunoassays in individuals from China.

本文引用的文献

1
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.医学上无法控制的继发性甲状旁腺功能亢进症的风险取决于血液透析开始时甲状旁腺激素水平。
Nephrol Dial Transplant. 2021 Jan 1;36(1):160-169. doi: 10.1093/ndt/gfaa195.
2
Parathyroid Hormone: A Uremic Toxin.甲状旁腺激素:一种尿毒症毒素。
Toxins (Basel). 2020 Mar 17;12(3):189. doi: 10.3390/toxins12030189.
3
Sympathetic Activation in Hypertensive Chronic Kidney Disease - A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
假性甲状旁腺功能减退症 1 型和原发性甲状旁腺功能亢进症中全长和完整 PTH 浓度:来自中国个体的免疫分析临床评估。
Endocrine. 2022 Dec;78(3):605-614. doi: 10.1007/s12020-022-03204-7. Epub 2022 Oct 11.
4
Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism.甲状旁腺切除术对伴有严重甲状旁腺功能亢进的非糖尿病血液透析患者的影响。
Ren Fail. 2022 Dec;44(1):1160-1168. doi: 10.1080/0886022X.2022.2098768.
5
Fibroblast growth factor-23 and parathyroid hormone suppress small intestinal magnesium absorption.成纤维细胞生长因子 23 和甲状旁腺激素抑制小肠镁吸收。
Physiol Rep. 2022 Apr;10(7):e15247. doi: 10.14814/phy2.15247.
高血压慢性肾脏病中的交感神经激活——心律失常和心源性猝死的诱因?
Front Physiol. 2020 Jan 14;10:1546. doi: 10.3389/fphys.2019.01546. eCollection 2019.
4
Sleep heart rate variability assists the automatic prediction of long-term cardiovascular outcomes.睡眠心率变异性有助于自动预测长期心血管结局。
Sleep Med. 2020 Mar;67:217-224. doi: 10.1016/j.sleep.2019.11.1259. Epub 2019 Dec 16.
5
Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives.慢性肾脏病-矿物质和骨异常(CKD-MBD):当前观点
Int J Nephrol Renovasc Dis. 2019 Dec 24;12:263-276. doi: 10.2147/IJNRD.S191156. eCollection 2019.
6
Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.慢性肾脏病中甲状旁腺激素的检测:从基础到临床意义
Int J Nephrol. 2019 Sep 17;2019:5496710. doi: 10.1155/2019/5496710. eCollection 2019.
7
Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.慢性肾脏病继发性甲状旁腺功能亢进症管理中的争议。
Curr Osteoporos Rep. 2019 Oct;17(5):333-342. doi: 10.1007/s11914-019-00533-x.
8
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
9
Parathyroidectomy in dialysis patients: Indications, methods, and consequences.透析患者的甲状旁腺切除术:适应症、方法及后果
Semin Dial. 2019 Sep;32(5):444-451. doi: 10.1111/sdi.12772. Epub 2019 Jan 17.
10
Parathyroid Hormone Fragments: New Targets for the Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.甲状旁腺激素片段:慢性肾脏病-矿物质和骨异常诊断和治疗的新靶点。
Biomed Res Int. 2018 Nov 29;2018:9619253. doi: 10.1155/2018/9619253. eCollection 2018.